Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reliability of Expired Allergens in Patch Testing
NCT07765563Phase 4Not yet recruiting
- Sponsor
- University of Calgary
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in allergic contact dermatitis (ACD), sponsored by University of Calgary. Primary endpoint: Patch Testing Response (Positive/Negative) Concordance Rate Between Non-Expired and Expired Allergens at Day 5. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
allergic contact dermatitis (ACD)
Beyond the preview
Go deeper on NCT07765563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765563.